Myrtelle Announces Presentation at the 5 th Annual Gene Therapy for Neurological Disorders Summit: Optimizing Gene Therapies Targeting the CNS to Deliver Safe & Efficacious Treatment Options For Neurological Disorder Patients
Wakefield, Mass., November 7, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a clinical-stage gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Article Date
November 6, 2023
This article is featured on another website.
Go to article
March 13, 2026
Connect with HiRO at the 2026 AAD Annual Meeting
Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…
March 13, 2026
Connect with HiRO at the 2026 AAD Annual Meeting
Heading to the 2026 AAD Annual Meeting? Connect with the HiRO Team in Denver The…
January 28, 2026
Taiwan & Hong Kong: Strategic Hubs for Global Development
The APAC region continues to play a critical role in the global landscape of drug…
January 28, 2026
Taiwan & Hong Kong: Strategic Hubs for Global Development
The APAC region continues to play a critical role in the global landscape of drug…